The WACC of Xvivo Perfusion AB (XVIVO.ST) is 7.1%.
| Range | Selected | |
| Cost of equity | 5.50% - 8.70% | 7.10% |
| Tax rate | 13.10% - 19.40% | 16.25% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.5% - 8.7% | 7.1% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.38 | 0.68 |
| Additional risk adjustments | 1.0% | 1.5% |
| Cost of equity | 5.50% | 8.70% |
| Tax rate | 13.10% | 19.40% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.5% | 8.7% |
| Selected WACC | 7.1% | |